Skip to main content
OpenTrials

Clinical trial condition

Adnexal Diseases

Explore clinical trials studying Adnexal Diseases. Study availability and eligibility vary by location and protocol.

3,513 public trials 681 recruiting studies
Refine in advanced search Browse all conditions

Adnexal Diseases trial results

Completed

APA on Sleep Quality in Women With PCOS

NCT06009172

Conditions
Adnexal Diseases, Cysts, Endocrine System Diseases, +10 more
Locations
  • Department of Endocrinology and Diabetes, the First Affiliated Hospital of Xiamen University, School of medicine, Xiamen university, Xiamen, China Xiamen, Fujian, China
View Trial Details
Completed

Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer

NCT00993655

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +33 more
Locations
  • Mercy-Springfield Springfield, Missouri, United States
  • CoxHealth Springfield, Missouri, United States
  • University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
  • Women and Infants Hospital of Rhode Island Providence, Rhode Island, United States
View all 50 locations
View Trial Details
Completed

Ask Questions (ASQ):Implementation of a Communication Intervention

NCT05025748

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +68 more
Locations
  • Karmanos Cancer Institute at McLaren Bay Region Bay City, Michigan, United States
  • Karmanos Cancer Institute at McLaren Clarkston Clarkston, Michigan, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Karmanos Cancer Institute at McLaren Flint Flint, Michigan, United States
View Trial Details
Completed

A Clinical Study of Cobimetinib Administered in Combination With Niraparib, With or Without Atezolizumab to Patients With Advanced Platinum-sensitive Ovarian Cancer

NCT03695380

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • University of Arizona Cancer Center, North Tucson, Arizona, United States
  • Moores Cancer Center at UC San Diego Health La Jolla, California, United States
  • Mayo Clinic-Jacksonville Jacksonville, Florida, United States
  • Florida Hospital Cancer Institute; Clinical Research Department Orlando, Florida, United States
View all 20 locations
View Trial Details
Completed

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

NCT03602079

Conditions
Adenocarcinoma, Adnexal Diseases, Bile Duct Cancer, +129 more
Locations
  • Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
  • Beth Israel Deaconess Medical Center Cancer Center Boston, Massachusetts, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Clinical Research Alliance, Inc. Lake Success, New York, United States
View Trial Details

Related conditions